Anticoagulant Citrate Phosphate Dextrose (cpd) Blood-pack Units In Pl 146 Plastic Solution
NDC Package 0942-9202-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Anticoagulant Citrate Phosphate Dextrose (cpd) Blood-pack Units In Pl 146 Plastic (anticoagulant citrate phosphate dextrose (cpd)) solution is classified as a

administered via intravenous route. This formulation utilizes a solution delivery system. Marketed by Fenwal, Inc., this product is identified by NDC 0942-9202 and is authorized under FDA application BN170401.

Identification & Billing

NDC Package Code
0942-9202-01
Package Description
63 mL in 1 BAG
Product Code
0942-9202
11-Digit Billing Format
00942920201

Clinical Specifications

Proprietary Name
Anticoagulant Citrate Phosphate Dextrose (cpd) Blood-pack Units In Pl 146 Plastic
Non-Proprietary Name
Anticoagulant Citrate Phosphate Dextrose (cpd)
Substance Name
Anhydrous Citric Acid; Dextrose Monohydrate; Sodium Phosphate, Monobasic, Monohydrate; Trisodium Citrate Dihydrate
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Fenwal, Inc.
Product Type
Human Prescription Drug
FDA Application #
BN170401
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-31-2007
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0942-9202-01 identifies a specific commercial package of 63 ml in 1 bag of Anticoagulant Citrate Phosphate Dextrose (cpd) Blood-pack Units In Pl 146 Plastic, a human prescription drug labeled by Fenwal, Inc.. This solution is formulated for intravenous use and contains anhydrous citric acid; dextrose monohydrate; sodium phosphate, monobasic, monohydrate; trisodium citrate dihydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fenwal, Inc. on March 31, 2007. The current certification is valid through December 31, 2026.

How is this Fenwal, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00942920201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0942-9202-01
11-Digit CMS (5-4-2)
00942-9202-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.